Clinical Trial Update: Miltefosine and GM-CSF in Cutaneous Leishmaniasis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating miltefosine with GM-CSF for cutaneous leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Miltefosine (miltefosine)

Snippet

Sponsor: Hospital Universitário Professor Edgard Santos | Conditions: Cutaneous Leishmaniasis | Phase 3 | Status: COMPLETED